Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04752189 · ClinicalTrials.gov registry record · NA

Preventing Substance Use Among Youth

A NA study, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
825
Enrollment target

NCT04752189: Completed NA study, sponsored by Wayne State University.

NCT04752189 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 825 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04752189, a NA study, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
825 participants
Enrollment target

Study Summary

Using a 2-group, mixed method group randomized trial design, this pilot study will compare standard implementation versus Enhanced Replicating Effective Programs (Enhanced REP) to deliver Michigan Model for Health (MMH) in Michigan high schools.

Primary Outcome

To evaluate comprehensively curriculum feasibility, the investigators used the Consolidated Framework for Implementation Research (CFIR) interview guide to guide the qualitative investigation of using Standard MMH Implementation or MI-LEAP for MMH delivery. The semi-structured interview guide was designed to elicit specific feedback on REP and Enhanced REP components (manual, training, and facilitation) and their feasibility to deliver MMH. We used reflexive thematic analysis to generate initia

Interventions

  • BEHAVIORAL Standard implementation
  • BEHAVIORAL Enhanced Replicating Effective Programs (Enhanced REP)

Trial Details

FieldValue
Enrollment Target 825 participants
Start Date 2021-08-04
Est. Completion 2022-07-14
Phase NA
Wayne State University

163 total trials

What the finished NCT04752189 record still lists

NCT04752189 is an interventional study that assigns participants to a tested intervention. The registered 825 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard implementation is the first listed.

NCT04752189 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04752189 about?

NCT04752189 is a clinical study titled "Preventing Substance Use Among Youth". Using a 2-group, mixed method group randomized trial design, this pilot study will compare standard implementation versus Enhanced Replicating Effective Programs (Enhanced REP) to deliver Michigan Model for Health (MMH) in Michigan high schools.

What is the current status of trial NCT04752189?

This trial is currently completed. It is a NA study. The enrollment target is 825 participants. The study started on 2021-08-04. Estimated completion is 2022-07-14.

What interventions are being tested in trial NCT04752189?

The interventions under investigation include: Standard implementation (BEHAVIORAL), Enhanced Replicating Effective Programs (Enhanced REP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04752189?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04752189's enrollment target sits among peer trials

825 134th of 2000 higher than 1,867 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05630482 · 825 participants · NA

    Randomized Trial of Healthy Family Foundations

  • NCT06097728 · 825 participants · Phase 3

    MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

  • NCT07102641 · 825 participants · Phase 4

    Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies

  • NCT07318077 · 825 participants · NA

    Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04752189, the US trial registry maintained by the National Library of Medicine. NCT04752189 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.